论文部分内容阅读
联合化疗对晚期乳腺癌的客观有效率可达46～90%,但复发后再应用常规联合化疗则只有22～50%,著者考虑是由于对药物产生抗药性等原因所致,故选用一种新化疗方案(VATH),以期能提高对常规联合化疗产生抗性的晚期乳腺癌的疗效。
The objective efficiency of combination chemotherapy for advanced breast cancer can reach 46 to 90%, but only 22 to 50% of conventional chemotherapy can be used after recurrence. The authors consider that it is due to drug resistance and other reasons, so choose one The new chemotherapy regimen (VATH) is expected to improve the efficacy of advanced breast cancer that is resistant to conventional combination chemotherapy.